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Background: Live attenuated SIV induces potent protection against superinfection with virulent virus; however the
mechanism of this vaccine effect is poorly understood. Such knowledge is important for the development of
clinically acceptable vaccine modalities against HIV.
Results: Using a novel, doxycycline dependent, replication-competent live-attenuated SIVmac239Δnef (SIV-
rtTAΔnef), we show that under replication-permissive conditions SIV-rtTAΔnef is fully viable. Twelve rhesus
macaques were infected with a peak plasma vRNA on average two log10 lower than in 6 macaques infected with
unconditionally replication-competent SIVΔnef. Consistent with the attenuated phenotype of the viruses the
majority of animals displayed low or undetectable levels of viraemia by 42-84 days after infection. Next, comparison
of circulating T cells before and after chronic infection with parental SIVΔnef revealed a profound global
polarisation toward CD28-CCR7- T-effector memory 2 (TEM2) cells within CD95
+CD4+ and CD95+CD8+ populations.
Critically, a similar effect was seen in the CD95+ CD4+ population and to somewhat lesser extent in the CD95+
CD8+ population of SIV-rtTAΔnef chronically infected macaques that were maintained on doxycycline, but was not
seen in animals from which doxycycline had been withdrawn. The proportions of gut-homing T-central memory
(TCM) and TEM defined by the expression of α4β7 and CD95 and differential expression of CD28 were increased in
CD4 and CD8 cells under replication competent conditions and gut-homing CD4 TCM were also significantly
increased under non-permissive conditions. TEM2 polarisation was seen in the small intestines of animals under
replication permissive conditions but the effect was less pronounced than in the circulation. Intracellular cytokine
staining of circulating SIV-specific T cells for IL-2, IFN-γ, TNF-α and IL-17 showed that the extent of polyfunctionality
in CD4 and CD8 T cells was associated with replication permissivity; however, signature patterns of cytokine
combinations were not distinguishable between groups of macaques.
Conclusion: Taken together our results show that the global T memory cell compartment is profoundly skewed
towards a mature effector phenotype by attenuated SIV. Results with the replication-conditional mutant suggest
that maintenance of this effect, that may be important in vaccine design, might require persistence of replicating
virus.
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Because of the predilection of human and simian im-
munodeficiency viruses to replicate in cells of the im-
mune system and particularly in CD4 T cells it is an
extremely complex task to unravel the exact relationships
between viral dynamics, influenced by virus and host
phenotype and the cognate adaptive and innate immune
responses. These responses are themselves influenced dir-
ectly by virus replication and bystander effects driven by
inappropriate immune activation and immunosuppres-
sion. It is however clear that T cell immune responses
have a profound influence on on-going virus replication as
evidenced by (1) the temporal relationship between their
appearance and the down-turn in concentrations of
plasma vRNA [1,2], (2) the strong selective pressure
exerted on T cell epitope recognition [3,4] and (3) experi-
ments in SIV-infected macaques where selective depletion
of CD8 T cells correlated with reduced virus control [5,6].
Conversely, the generation of T cell responses is driven by
virus replication and antigen expression which themselves
are modulated by the effects of the virus on the integrity
of the immune system including continuous immune acti-
vation characterised by increased T cell turnover, the pro-
duction of pro-inflammatory cytokines and distinct B cell
dysfunction [7-9]. Moreover, it is now realised that infec-
tion has a profound and early impact on the gut epithelial
barrier associated with local inflammation and loss of in-
tegrity of the mucosal immune system. Since the gut
accommodates a rich environment of microbes and mi-
crobial products, its damage may cause increased perme-
ability and translocation of microbial products into the
periphery fuelling continuous systemic immune activation,
a hallmark of HIV/SIV pathogenesis [10,11].
The use of SIV mutants in the macaque model allows
the dissection of the complex interplay between the host
and virally-encoded pathogenesis factors and has been
critical in revealing the ability of attenuated virus to in-
duce a state of superinfection resistance in vivo. It is well
established that removal or interruption of the viral
accessory gene nef attenuates HIV and SIV in vivo
resulting in the early acute phase viraemia progressing
to a very low set-point where virus rarely if ever is
detected in the peripheral circulation either by virus iso-
lation from peripheral blood mononuclear cells (PBMC)
or by RT-PCR amplification of vRNA [12,13]. This at-
tenuated peripheral phenotype of viral replication is as-
sociated with the generation of CD8 and CD4 T cell
responses which are widely disseminated and detectable
at mucosal sites regardless of the virus portal of entry.
Moreover, macaques infected with attenuated SIV display
potent resistance to subsequent superinfection challenge
with cell-free homologous and heterologous viruses in-
cluding chimeric SIV expressing HIV envelope [14-16]
and virus infected cells [17]. Furthermore, protectionextends to mucosal challenge [16,18,19]. Even when
superinfection does occur, disease progression appears to
be ameliorated by the effects of the pre-existing attenu-
ated virus [12]. Although, taken together, these findings
suggest that live attenuated vaccination would be an ap-
proach to vaccination against HIV safety issues including
reversion to virulence by mutation [20] and differential
pathogenicity dependent upon host factors [21] have pre-
cluded direct development of this strategy. Nonetheless,
mechanistic insight into this powerful effect will inform
rational design of clinically acceptable vaccines.
To more fully understand the live attenuated vaccine
effect it is imperative to define the parameters required
for protection. As for other attenuated virus vaccines it
is known that protection is influenced by the degree of
attenuation, as reflected in the acute peak of plasma vir-
aemia [22,23]. However, less is known about events fol-
lowing clearance of attenuated virus from the peripheral
circulation. In this study we were interested to deter-
mine the attenuated vaccine-driven T cell environment
and cognate T cell responses under conditions where
on-going replication in tissues (occult replication) was
permitted compared to non-replication permissive condi-
tions. To address this issue we have used a novel condi-
tionally replication competent variant of SIVmac239Δnef
(SIVΔnef ): a prototypic attenuated SIV that confers potent
protection against superinfection [12]. The conditional
mutant, designated SIVmac239rtTAΔnef (SIV-rtTAΔnef ),
replicates exclusively when doxycycline (dox) is adminis-
tered in vitro [24,25].
We show here in rhesus macaques that SIV-rtTAΔnef
replicated in vivo in the presence of orally administered dox
and drives polarisation of the global circulating T cell mem-
ory compartment toward a TEM phenotype, most notably
in the fully differentiated TEM2 population (CD95
+CD28-
CCR7-). A similar effect was seen in SIVΔnef -infected
macaques. Critically this phenotype was not seen following
withdrawal of dox in SIV-rtTAΔnef -infected macaques i.e.
under replication non-permissive conditions. Maintenance
of gut-homing α4+β7+ TEM (CD95
+CD28-) also was
dependent on replication permissivity whereas increased
proportions of CD4 and CD8 α4+β7+ TCM (CD95
+CD28+)
were observed in SIV-rtTAΔnef -infected macaques in both
the continued presence of dox and following withdrawal of
dox. Analysis of small intestine tissues demonstrated
marked differences in vRNA and Env antigen staining in-
tensity and distribution between macaques infected with
SIV-rtTAΔnef under replication permissive and non-per-
missive conditions and animals infected with SIVΔnef;
however, polarisation of global T cell memory phenotypes
was less pronounced in cells extracted from small intestine.
Analysis of SIV-antigen driven T cell polyfunctionality re-
vealed no clearly defined IL-2, IFN-γ, TNF-α and IL-17 sig-
nature with respect to virus replication dynamics at the
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CD8 circulating or small intestinal T cell populations; how-
ever, the degree of polyfunctionality was related to replica-
tive capacity and replication permissivity.
Results
SIV-rtTAΔnef had an attenuated phenotype in vivo with
reduced acute phase replication compared to SIVΔnef
A total of 12 macaques, pre-dosed with dox for 14 days
were inoculated with SIV-rtTAΔnef and maintained on
dox for a further 175 days (Groups A & B). Six animals
were followed for a further 56 days following withdrawal
of dox (Group A) and a further 6 animals were inocu-
lated with SIVΔnef in the absence of dox (Group C). All
animals were successfully infected resulting in median
peak plasma vRNA loads of 4.34 × 103 (range 9.44 × 102 –
2.49 × 104) vRNA copies/ml for SIV-rtTAΔnef and 2.95 ×
105 (range 1.32 × 104 – 7.73 × 105) vRNA copies/ml for
SIVΔnef (Figure 1); the median peak load being significantlyTim
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Figure 1 Comparative viral replication dynamics. Plasma viraemia and
RT-PCR and quantative PCR respectively over time in rhesus macaques infe
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grey stippled bars indicate the period of dox administration. Green lines an
immunological parameters in tissues.lower in SIV-rtTAΔnef -infected macaques (ρ = 0.001,
Mann–Whitney rank sum test). Otherwise, in general,
plasma vRNA load kinetics followed a typical attenuated
pattern with an acute peak typically 14 days post infec-
tion (p.i.); although occasionally as late as 28 days p.i.
followed by a rapid decline with vRNA dropping below
the limit of detection between 42 and 84 days p.i. and
remaining undetectable or with transient peaks of <120
vRNA/copies/ml thereafter. SIV-rtTAΔnef -infected ma-
caques E65 and E70, both with delayed peak viraemia
(28 days p.i.), had relatively high “set points” of >100
vRNA copies/ml, although in E65, levels had declined
by 140 days p.i. Surprisingly however, despite with-
drawal of dox from 175 days p.i., two transient peaks of
plasma viraemia were detected in this animal. Macaque
E74, infected with SIVΔnef, exhibited a high set-point of
approximately 103 copies/ml and macaque E76, despite
an initial decline in vRNA, displayed a progressive re-
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proviral DNA loads in PBMC were measured by quantative real-time
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tion (E61), infected macaques had a peak of proviral
DNA 14- 22 days p.i. regardless of the infecting virus;
however, the median peak frequency of proviral DNA
was significantly lower (ρ < 0.001, Mann Whitney rank
sum test) in macaques infected with SIV-rtTAΔnef (4.38
copies/105 cell equivalents) compared with animals
infected with SIVΔnef (371copies/105 cell equivalents)
(Figure 1). Following withdrawal of dox from Group A,
proviral DNA was undetectable in 3 macaques but
detected transiently and at <5 copies/105 cell equivalents
in the remaining 3 SIV-rtTAΔnef -infected macaques.
Comparison of peak and day 175 plasma vRNA and
proviral DNA concentrations showed no statistical dif-
ferences between Groups A and B (vRNA peak: ρ =0.31;
vRNA d175: ρ =0.94; proviral DNA peak: ρ =0.39; pro-
viral DNA d175: ρ =0.31, Mann–Whitney rank sum test)
indicating no significant differences in virological changes
between these groups of animals before cessation of dox.
Differential localisation of SIV-rtTAΔnef and SIVΔnef in
tissues
Two animals from each group were killed humanely
230 days p.i. (Group A; 56 days after withdrawal of
doxycycline) or 160-167 days p.i. (Groups B & C) for
analysis of bio-distribution and T cell composition in
small intestine. Proviral DNA was detected in all tissues
analysed from macaques infected with SIVΔnef, gener-
ally at concentrations exceeding those in PBMC
(Table 1). Likewise animals infected with SIV-rtTAΔnef
and maintained on dox had widely distributed proviral
DNA but concentrations overall were lower than those
in animals of Group C, particularly in spleen and mesen-
teric lymph nodes. A further reduction in proviral DNA
concentration was seen in the spleens and peripheral
lymph nodes of the two SIV-rtTAΔnef-infected ma-
caques from which dox had been withdrawn. Proviral
DNA was not detected in the thymus of SIV-rtTAΔnef -Table 1 Proviral DNA loads in tissues
Animal No. SIV DNA copies/105 MNC
SlV-rtTAΔnef SlVΔnef
Dox withdrawn Dox maintained
E62 E64 E69 E72 E74 E78
PBMC <1a <1 1.37 <1 2.59 2.63
Spleen 1.79 2.47 10.3 8.02 95.0 25.83
Peripheral LNb <1 1.46 12.1 88.4 50.1 50.3
Thymus <1 <1 <1 <1 NDc ND
Mesenteric LN <1 4.93 4.61 1.92 178.2 120.3
Small intestine <1 <1 <1 4.27 3.87 7.38
Large intestine 1.31 2.58 4.4 2.68 1.88 12.8
a < indicates below the limit of detection; b LN lymph node, c ND not done.infected animals and was detected in the small intestine
in only one animal, when dox was maintained. To inves-
tigate further whether persisting proviral DNA was
transcriptionally active with or without doxycycline
quantitative rtPCR was performed on cellular RNA iso-
lated from spleen, PLN and MLN samples. Detectable
signals between 102 and 105 copies per 50 ng total RNA
were detected in these tissues in E74 infected with
SIVΔnef and a signal of 248 copies per 50 ng total RNA
from E78 also infected with the same virus. Amongst
macaques infected with the doxycycline dependent SIV-
rtTA Δnef signals just above the cut-off value of the
assay (20 copies per 50 ng total RNA) were detected in
selected tissues from E69 and E72 that were still receiv-
ing doxycycline. No signals above cut-off were detected
in macaques infected with SIV-rtTA Δnef where doxy-
cycline had stopped being administered 56 days before
the tissues were analysed.
Since the small intestine is a major site for virus repli-
cation we were interested to determine bio-distribution
in this tissue. Haematoxylin and eosin staining revealed
no gross pathology regardless of virus status (data not
shown). Next, sections of small intestine from each ani-
mal were examined by immunohistochemistry using an
SIV-Env specific monoclonal antibody for the presence
of SIV envelope (Figure 2a-c). Group A macaques had
very low levels of envelope detection throughout all re-
gions of the small intestine including Peyer’s patches. By
contrast Group B & C macaques demonstrated moder-
ate levels of envelope detection within Peyer’s patches
and associated germinal centres, extending to nearby
crypts in Group C animals.
The presence of SIV-infected cells within the small in-
testine was examined by in situ hybridisation using a
cocktail of three probes complementary with SIV RNA
transcripts (Figure 2d-f ). Whilst SIV positive cells were
detected within the small intestine of all animals the
numbers and positioning of these cells differed between
groups. Sections of small intestine from Group A ani-
mals contained very low levels of SIV productively-
infected cells within T cell areas of the lamina propria.
Analysis of sections from Group B and Group C small
intestine demonstrated the presence of increased num-
bers of SIV positive cells within Peyer’s patches with
those from Group B animals being present largely within
the marginal/mantle zones surrounding secondary
follicle germinal centres and those within Group C ani-
mals being mainly clustered within the germinal centres
themselves.
Active replication of attenuated SIV reconfigured the
composition of the memory T cell compartment
To investigate the impact of infection on memory T cell
phenotype, T central memory (TCM) and T effector
Group A: SIV-rtTA dox withdrawn Group B: SIV-rtTA dox maintained Group C: SIVΔnef
a b c
d e f
Figure 2 Distribution of SIV envelope antigen and SIV RNA in small intestine. Representative images show (a-c) immunohistochemical
staining for anti-SIV envelope (brown cell surface staining) and (d-f) in situ hybridisation for replicating SIV (purple stained cells). Low levels of
anti-envelope staining within the lamina propria/villi of Group A animals (a) corresponds to sites of low level viral replication (d, arrows). Higher
levels of anti-envelope staining within the follicular marginal zones of Group B animals (b) and follicles of Group C animals (c) also correspond to
sites of increased levels of viral replication (e, arrows; f, within oval). Magnification ×100.
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+CD4+ and
CD3+CD8+ -gated populations by staining for expression
of CD95 and CD28 according to Pitcher et al., [26]
(Figure 3a). CD4+ T cells from macaques infected with
SIVΔnef, showed a statistically significant reduction (ρ =
0.013; paired t-test) in TCM (CD95
+, CD28+) with a
concomitant increase (ρ = 0.004; paired t-test) in the
proportion of TEM. A similar trend was seen in animals
infected with SIV-rtTAΔnef under replication permissive
conditions but did not reach statistical significance;
whereas, under replication non-permissive conditions,
following withdrawal of dox, only random changes were
seen (Figure 3b, c). In the CD8 memory T cell populations,
a similar trend was seen although statistical significance
was reached only in the increase in the proportions of
TEM in animals infected with SIV-rtTA maintained on dox
(ρ = 0.024; paired t-test) (Figure 3d, e).
Next, we determined the expression of CD28 and
CCR7 on CD95+ CD4+ and CD8+ T cells. Thus memory
cell populations were defined along the TCM to TEM dif-
ferentiation axis according to Picker et al [27,28] as T
central memory (TCM) CD28
+CCR7+; transitional effector
memory (TEM1) CD28
+CCR7- and fully differentiated ef-
fector memory (TEM2) CD28
-CCR7-. Both SIV-rtTAΔnef -
dox-maintained and SIVΔnef -infected animals, displayeda strong polarisation to a global CD4+ TEM2 phenotype,
with a corresponding significant reduction in TCM fre-
quency (Figure 4). Similar trends were observed in the
CD8+ T cell populations; although statistical significance
was reached only in SIVΔnef -infected animals. In addition
a significant polarisation toward TEM1 was seen in both
CD4 and CD8 cells from animals infected with SIVΔnef
with only animal E77 being an exception; whereas, only a
proportion of infected-animals of group B had an increase
in this subset. Of particular note, global polarisation
toward TEM2 was not evident in animals of Group A,
indicating that replication-permissive conditions were ne-
cessary for the maintenance of this phenotype.
To investigate whether SIV- or dox-induced transloca-
tion of microbial products from the gut may be driving
the extensive T cell polarisation observed, LPS and
sCD14 were quantified by ELISA in plasma from naïve
dox-treated, SIV-rtTAΔnef, SIVΔnef and wild-type SIV-
infected animals. LPS was undetectable and concentra-
tions of sCD14 were close to undetectable in all animals
except those infected with wild-type SIV (Additional file
1: Figure S1). Furthermore, the proportions of CD4+ and
CD8+ T cells with effector memory phenotype in the
blood of these animals fell within the ranges measured
in non-dox treated naïve macaques.
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http://www.retrovirology.com/content/10/1/59Viral replication imprinted expression of the gut homing
marker α4β7 on CD95+ T cells
Because the gut associated lymphoid tissue (GALT) is a
primary site of SIV and HIV replication regardless of the
viral route of entry [29] and the α4β7 integrin, specific-
ally expressed on gut-homing T cells, is upregulated in
SIV/HIV infection [30] and may play an important role
in pathogenesis, we were interested to determine theeffect of viral replication status on α4β7 subsets. Infec-
tion with either SIV-rtTAΔnef or SIVΔnef induced α4
+β7+ CD4+CD95+ and CD8+CD95+ TCM and TEM sub-
sets although the change in CD4+ TEM cells failed to
reach statistical significance the result was skewed by
macaque E67, which also was an exception in the CD8+
TEM population (Figure 5). Interestingly, while active
viral replication was necessary to maintain α4+β7+ TEM
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http://www.retrovirology.com/content/10/1/59in both CD4 and CD8 populations, α4β7 expression was
imprinted on CD4 and CD8 TCM from the majority of
animals infected with SIV-rtTAΔnef from which dox had
been withdrawn for 56 days i.e. under non-permissive
conditions for viral replication.Gut-resident T cells from macaques with actively
replicating SIV were polarised toward TEM2 but less so
than were circulating T cells
Next, we analysed T cell phenotypes in MNC isolated
from the small intestines of two animals from each
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http://www.retrovirology.com/content/10/1/59group at necropsy together with cells from two unin-
fected, dox-dosed animals as controls. There was no
evidence of SIV-induced reduction in the proportion of
CD4+ cells in the small intestine with the possible excep-
tion of E78 (infected with SIVΔnef ); although higherfrequencies of CD8+ T cells were observed in all SIV-
infected animals compared with controls. Interestingly,
the profound global polarisation toward TEM1 and par-
ticularly TEM2 phenotype seen in the blood of animals
under replication permissive conditions was less apparent
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similar with respect to the fully matured TEM2 phenotype
but was not evident in the intermediate TEM1 populations
of CD4+ and CD8+ cells (Table 2).
Total polyfunctionality of SIV-specific peripheral T cells
was associated with replication permissivity but group-
specific cytokine signatures were not evident
Having established that replication permissive conditions
were associated with driving the peripheral and to some
extent the small intestinal global T cell population to-
ward a TEM2 phenotype in both the CD4 and CD8 com-
partments, we sought to determine whether replication
permissivity influenced the quality and quantity of SIV-
specific T cells. Following stimulation in vitro with SIV
Gag, Rev or Tat peptide pools, polychromatic flow cy-
tometry was employed to analyse intracellular staining
for IFN-γ, IL-2, TNF-α, and IL-17. First, we determined
the proportion of macaques in each group showing
maximum polyfunctionality, regardless of frequency or
individual antigen specificity. Thus, for CD4+ T cells 50
percent of the SIVΔnef-infected animals exhibited the
highest degree of polyfunctionality, whereas 66.6% of an-
imals infected with SIV-rtTAΔnef maintained on dox
had a maximum of 3 functions and 1 of 6 and 2 of 6 ani-
mals infected with SIV-rtTAΔnef from which dox had
been withdrawn had 4 or 3 functions respectively
(Figure 6a). For CD8+ T cells, all animals of Group C
had polyfunctional cells, 50% of Group B animals had 4
functions and the remaining animals had 3 functions
and 50% of animals from Group A had 4 functions but
the remaining animals each had 3, 2 or 1 functions
(Figure 7a). Taken together, these results indicate that
the likelihood of exhibiting SIV-polyfuctionality with re-
spect to the cytokines analysed was associated with the
replicative capacity and status of the infecting virus.
Next, we sought to determine whether SIVΔnef and SIV-
rtTAΔnef-infected macaques under replication permissiveTable 2 Immunophenotype of small intestinal MNC (%)
Animal No. Uninfected controls SIV-rtT
Dox maintained Dox wi
J9 J1O E62
CD4 47.7 44.6 55.1
CD4+CD95+CD28+CCR7+ 37.9 65 57.6
CD4+CD95+CD28+CCR7- 27.2 13.8 13.4
CD4+CD95+CD28-CCR7- 17.2 10.9 9.3
CD8 26.8 28.7 44.0
CD8+CD95+CD28+CCR7+ 36.2 43.8 32.7
CD8+CD95+CD28+CCR7- 16.8 21.7 17.5
CD8+CD95+CD28-CCR7- 26.2 18.9 34.4
ND not done.and non-permissive had distinguishable patterns of SIV
antigen-specific T cell cytokine responses as it may be pos-
sible eventually to identify protective T cell signatures. The
frequencies of SIV-specific cytokine secreting cells were
analysed with respect to all combinations of cytokines for
each infection group. In both CD4+ and CD8+ populations
there was a high degree of animal to animal variability in
cell frequency regardless of virological status (Figures 6b &
7b) and a high degree of variability in the proportion of an-
imals with reactive cells for each cytokine combination
(Figures 6c & 7c); however, there was a trend to higher
overall polyfunctionality in CD8+ cells, most notably in ani-
mals under replication permissive conditions. CD4+ IL-17+
cells were found principally as single secretors, particularly
in rtTA dox-maintained animals and in combination with
TNF-α; whereas, CD8+ IL-17+ cells were virtually absent in
all groups (Figure 7).
The relatively small sample size precluded detailed
statistical analysis at the level of individual cytokine
combinations and antigen specificity with respect to in-
dividual cell frequencies; therefore the data was analysed
by principal component analysis with respect to CD4
and CD8 expression, frequency and proportion of SIV-
specific responses to the 15 combinatorial cytokine pat-
terns. Although several outlier individuals were evident,
overall no signature pattern was recognised with respect
to spatial clustering by infection group (Additional file 2:
Figure S2).
Total SIV-specific T cell frequencies were higher in the
small intestine compared with the peripheral circulation
and polyfunctionality was maintained under replication
non-permissive conditions
Flow cytometric analysis of intracellular cytokine stained
(ICS) T cells revealed that MNC contained higher fre-
quencies of SIV-specific T cells than were measured in
the peripheral circulation of the corresponding animals
(Figure 8). Sufficient cells were available from only oneA WT-SIVΔnef
thdrawn Dox maintained
E64 E69 E72 E74 E78
54.9 50.3 43.7 50.0 39.3
66.5 31.6 37.9 22.8 ND
9 26.4 6.2 5.2 ND
16.7 29 29.6 26 ND
43.1 48.9 49.8 45 51
36.4 19.7 26.7 22.8 ND
24.8 16.6 1.7 12.9 ND
27.7 40.5 45.3 36.3 ND
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Figure 6 Intracellular cytokine staining of SIV-specific CD4+ peripheral blood T cells. Cell populations were determined by multiparametric
flow cytometry. All analyses were performed at the end of the experimental infection schedule for each group of SIV-infected macaques. Pie
charts show the proportion of animals in each group with maximum polyfunctionality regardless of which SIV peptide pool was recognised (a).
Maximum polyfunctionality (4 parameter) is shown in black and descending degrees of polyfunctionality in shades of grey. Scatter charts show
the frequency distribution for each SIV peptide pool (different symbols) and the degree of polyfunctionality for animals of each group (different
colours) (b). Group A is shown in dark red, Group B in red and Group C in pink. Stacked bars show the number of animals in each group of 6
animals responding with each combination of cytokines (c).
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went to necropsy examination. Nonetheless, interest-
ingly, E64 (SIV-rtTAΔnef, dox withdrawn) had few, if
any, circulating SIV-specific T cells whereas CD4+ T cells
in the small intestine were predominantly IL-2, TNF-α,
IL17, and IL2, IFN-γ, TNF-α triple positive at high fre-
quency. Likewise, CD8+ small intestinal T cells from E64
had a high proportion of polyfunctional cells at high fre-
quency including ~20% expressing all 4 cytokines. Al-
though the overall frequency of antigen-specific T cells
was invariably higher in the small intestine compared
with the peripheral circulation (ρ < 0.001; paired t-test),
the proportion of polyfunctional cells and the frequency
combination was variable between the two compart-
ments. Again, it was not possible to discern any specific
signature of responsiveness either between compart-
ments or between animals from different groups.
Discussion
We have used a novel replication-conditional SIV-
rtTAΔnef to compare in vivo the influence of infectionon the global T memory cell compartment and the fre-
quency of SIV-specific polyfunctional T cells under repli-
cation permissive and non-permissive conditions at
times when, in the majority of macaques, vRNA was un-
detectable in the circulation. Results were compared to
those obtained from macaques infected with the parental
SIVΔnef. The SIV-rtTAΔnef construct had previously
been optimised for replication in rhesus macaque PBMC
through evolution in vitro without loss of dox-control
[25]. Here we have shown that this construct is fully in-
fectious in vivo in rhesus macaques and induces a simi-
lar overall pattern of plasma vRNAemia to SIV-Δnef.
The higher acute phase replication of the non-rtTA vari-
ant virus likely accounts for the higher proviral loads
detected particularly in spleen and mesenteric lymph
nodes of animals infected with this virus compared with
those infected with SIV-rtTAΔnef. Interestingly, lower
proviral loads were detected in spleen and peripheral
lymph nodes from dox-withdrawn animals, suggesting a
higher turnover of SIV-infected CD4+ T cells in these
tissues, which may therefore be primary sites of occult
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Figure 7 Intracellular cytokine staining of SIV-specific CD8+ peripheral blood T cells. Cell populations were determined by multiparametric
flow cytometry. All analyses were performed at the end of the experimental infection schedule for each group of SIV-infected macaques. Pie
charts show the proportion of animals in each group with maximum polyfunctionality regardless of which SIV peptide pool was recognised (a).
Maximum polyfunctionality (4 parameter) is shown in black and descending degrees of polyfunctionality in shades of grey. Scatter charts show
the frequency distribution for each SIV peptide pool (different symbols) and the degree of polyfunctionality for animals of each group (different
colours) (b). Group A is shown in dark blue, Group B in blue and Group C in cyan. Stacked bars show the number of animals in each group of 6
animals responding with each combination of cytokines (c).
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in peripheral lymph nodes of macaques E69 and E72
and the spleen of E72 which were infected with SIV-
rtTAΔnef and maintained on dox. Similar activity was
absent in the two macaques sampled from which dox
was withdrawn; however, this analysis is limited by the
sample size. Interestingly, much higher levels of SIV gag
transcripts were detected in the spleen and peripheral
lymph nodes of macaque E74 and the peripheral lymph
nodes of macaque E78; likely reflecting the higher repli-
cative fitness of SIVΔnef. Detection of vRNA by in situ
hybridisation and Env antigen by immunocytochemistry
in the absence of proviral DNA in the small intestines of
SIV-rtTA infected animals, albeit at very low levels in dox-
withdrawn animals, probably reflects the sensitivity of
these techniques to detect localized pockets of infection in
tissue that is otherwise free from SIV-infected cells. Rela-
tively high levels of Env staining were observed in dox-
maintained animals and in animals infected with SIV-Δnef
with those Env positive tissue regions not correlating to
sites of viral replication likely demonstrating trapping ofantigen by local antigen presenting cells including follicular
dendritic cells. It is also interesting to note that sites of
viral replication within the small intestine were subtly dif-
ferent between these groups of animals.
The reduction in peak viraemia and reduced proviral
load in PBMC seen with SIV-rtTAΔnef compared with
SIVΔnef demonstrates that despite optimisation of the
virus in vitro, the addition of the rtTA element had a fit-
ness-cost in vivo. Interestingly, two macaques infected
with SIV-rtTAΔnef and 2 macaques infected with SIVΔnef
displayed persisting plasma viraemia. We have observed a
similar effect in rhesus macaques using a minimally nef-
deleted virus [20]; however, the extent of nef -deletion in
the constructs used here make a direct repair of the at-
tenuating lesion impossible. Surprisingly, transient low
level plasma vRNA was detected in one SIV-rtTA-infected
macaque (E65) after withdrawal of dox. Interestingly, this
animal displayed persistence of plasma vRNAemia at >102
copies ml-1 for over 100 days p.i. One possible explanation
could be that a compensatory mutation for viral transacti-
vation may have arisen in progeny virus within this
Animal
No.
Virus T cell Total frequency (%)
periphery small intestine
E64 SIV-rtTAΔnef dox
withdrawn
0.09 5.109
E69 SIV-rtTAΔnef dox
maintained
CD4 2.931 5.237
E72 SIV-rtTAΔnef dox
maintained
3.12 8.576
E78 SIVΔnef 6.66 12.24
E64 SIV-rtTAΔnef dox
withdrawn
0 6.89
E69 SIV-rtTAΔnef dox
maintained
CD8 0.196 6.98
E72 SIV-rtTAΔnef dox
maintained
1.532 8.29
E78 SIVΔnef 4.998 7.9
Figure 8 Comparison of frequencies of SIV-specific T cells in the circulation and small intestine. Pie charts show the proportion of cells
expressing 4, 3, 2 or 1 cytokine with maximum polyfunctionality shown in black followed by shades of grey. Arcs show individual cytokine
combinations. IL-2 - red; IFN gamma - green; TNF-alpha - turquoise; IL-17 - blue.
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the dox control were found in the LTR promoter and rtTA
regions (data not shown). Very low levels of vRNA and
Env protein were detected in the small intestines of
dox-withdrawn animals which could be due to basal ac-
tivity of the LTR promoter in the absence of dox. This
promoter lacks a functional TAR element but contains
the natural NF-Kappa-B and Sp1 binding sites, which
are not sufficient to drive viral replication but may drive
low-level gene expression [24,25]. Furthermore, in some
cells the proviral LTR promoter may be activated by
transcriptional enhancer elements present at or near the
site of integration.
There was no evidence of elevated serum soluble
CD14 (Additional file 1: Figure S1); an indicator of loss
of intestinal epithelium integrity reported in chronic
pathogenic infection with HIV and wild-type SIV [11,31].
Neither was there evidence of histopathological changes
in the gut of those animals sampled, including one animal
with persistent viraemia. Nonetheless, within the global
circulating CD95+ T cell population there was a striking
polarisation toward an effector memory phenotype in ani-
mals where virus replication was permissible. This resultis consistent with data showing that SIVΔnef-infection
pushes the SIV-specific CD4 T cell response toward TEM
[32]; however, unexpectedly, the skewing effect described
here applies to the global CD4 population, regardless of
antigen specificity, and was also seen in the CD8+ T cell
population, albeit to a lesser extent. This polarising effect
was particularly apparent when the CCR7 receptor, im-
portant for secondary lymphoid tissue homing, was used
to differentiate TCM. Although macaques in group A had a
higher baseline proportion of CD4+ TEM2 than those of
Group B, these values fell within the range for all naïve
macaques including those of Group C. Given the extent of
the polarising effect seen in Groups B and C the pre-
existing baseline values in Group A were unlikely to have
influenced the result obtained after infection but this can-
not be absolutely ruled out. Since only a small proportion
of T cells are infected with SIV, it is evident that the
skewing of immunophenotype must be acting on by-
stander cells, either through SIV-encoded soluble prod-
ucts such as Env and Tat, through SIV-encoded products
released from dead and dying cells or from mediators aris-
ing as a result of SIV-induced dysregulation of lymphoid
system homeostasis. Whatever the exact mechanism,
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on-going virus replication, albeit occult, is required to
maintain TEM polarisation. It is likely that there is a crit-
ical threshold of replication required to drive perturbation
of the global T memory phenotype as (1) the effect is
strongest, extending to both CD4+ and CD8+ T cells in
macaques infected with SIVΔnef,; (2) not all macaques
infected with SIV-rtTAΔnef demonstrated the majority ef-
fect in the presence of dox i.e. macaque E68 had increased
CD4 TEM1, no significant increase in TEM2 and no propor-
tionate loss of TCM and displayed similar trends in CD8
+
memory T cells and (3) despite the transient detection of
plasma vRNA under dox-withdrawal in macaque E65 this
animal did not demonstrate significant perturbation of
memory phenotype while macaque E66 demonstrated a
skewing toward an increased frequency of CD4+ TEM1.
SIVΔnef induces α4β7+ gut mucosal-homing CD8+ T
lymphocytes [30] and more recent studies with HIV
have shown that α4β7 on CD4+ T cells may have a cen-
tral role in pathogenesis through interaction with gp120
and signalling [33]. Moreover, α4+β7hi memory T cells
are preferentially infected during acute pathogenic SIV
infection [34] and blocking α4β7 during acute infection
decreases local and plasma virus loads [35]. In the study
described here, analysis of expression of α4β7 on CD28+
and CD28- populations of CD95+ CD4 and CD8 T cells
showed that SIV infection in the majority of animals sig-
nificantly increased the proportion of mucosal homing
cells. Interestingly this effect appeared less dependent
upon on-going occult virus replication for maintenance
of CD95+ CD28+ T cells expressing α4β7 suggesting that
these cells may be long-lived. In contrast, animals infected
with non-attenuated SIVmac239 failed to show elevated
proportions of CD95 CD28+ α4+β7+ CD4 cells, although
the proportions of α4+β7+ TCM CD8 cells were increased
(data not shown). This observation is consistent with
α4β7 expression on circulating CD4+ T cells being a sur-
rogate marker of CD4+ T cell loss in the gut [36]. Indeed
the proportion of CD4+ small-intestinal MNC were not
decreased in attenuated SIV-infected macaques, even in
animal E74 with a persistent plasma viraemia; whereas,
the proportion of CD8+ cells was elevated. Furthermore
the relatively low proportions of small intestinal CD4+ T
cells and high proportions of CD8+ T cells in uninfected
animals is similar to results reported recently [37]. It is in-
teresting that the replication-dependent TEM polarisation
seen in the peripheral circulation was less pronounced in
the GALT and was confined to the terminally differenti-
ated TEM2 population; however, the small sample size
limits interpretation of this observation.
Antigen-specific polyfunctional CD8+ T cell responses
have been associated with positive control of immuno-
deficiency virus infection, for example in HIV-1 long
term non-progressors [38]; however, the extent to whichthese types of responses are important in the SIV live-at-
tenuated vaccine model is less clear. Also the relative
role of polyfunctional CD4+ T cell responses needs fur-
ther investigation. Infection of macaques with the novel
SIV-rtTAΔnef as described here may help to address
these issues. The finding that overall there were no con-
sistent differences in the patterns of cytokine combina-
tions in CD4+ and CD8+ circulating T cells between the
groups of macaques in the present study suggests that
the repertoire of T cell polyfunctionality in the circula-
tion is determined whilst virus is under replication-per-
missive conditions and was not overtly influenced by the
lower peak viraemia observed in rtTA-infected animals.
Although, only selected regions of the viral genome were
examined in this study at a single time point, it is un-
likely that significant differences between the groups
would be missed. Interestingly IL-17-producing CD4+
and CD8+ cells were present in the gut and peripheral
circulation despite their reported paucity following infec-
tion with virulent SIVmac [39,40] reflecting the attenu-
ated nature of the viruses used in this study. It was
notable that, in the small number of macaques studied,
the polyfunctionality of SIV-specific T cells was notably
different in individual animals when comparing systemic
and gut mucosal responses possibly reflecting regional
diversification of the T cell immune response. The lack
of particular signatures of T cell polyfunctionality in the
macaques may reflect the use of outbred animals where
there is greater plasticity of immune responsiveness than
seen in inbred species, such as mouse strains, frequently
used for immunological analysis of functional correlates
in infection.
Conclusions
Overall, this study has shown that live attenuated SIV
infection drives a global polarisation of T cell memory
phenotype, particularly in the CD4 population toward
effector memory. Moreover, maintenance of this effect
likely requires on-going replication that is largely un-
detectable in the circulation. Although replication non-
permissive conditions were associated with loss of
perturbation of circulating TEM, these conditions had lit-
tle, if any, effect on T cell polyfunctionality, at least with
respect to the cytokines examined. It will now be import-
ant to determine whether these changes in T cell subsets
influence the ability of animals infected with live attenu-
ated SIV to resist superinfection with virulent virus thus
informing rational design of vaccines against HIV. Recent
findings in macaques vaccinated with recombinant rhesus
cytomegalovirus expressing SIV genes strongly suggest that
SIV-specific TEM are crucial to early control of SIV follow-
ing challenge [41]. Moreover, whilst this paper was in
preparation, it has been reported that lymph node effector-
differentiated T cell responses predict the efficacy of live
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formally address the absolute requirement for dox in vivo,
particularly with respect to the possibility of low-level basal
transcription. The SIV-rtTAΔnef construct should be use-
ful to address issues such as whether constant or intermit-
tent tissue associated virus replication is necessary to
maintain TEM frequency at protective levels.
Methods
Animals and viruses
UK captive-bred rhesus macaques (Macaca mulatta) of
Indian origin, aged between 38 & 42 months at the start
of the experiment, were housed and maintained in accord-
ance with the Home Office (UK) Code of Practice (1998).
The study was approved by the NIBSC Ethics Committee.
Animals were sedated with ketamine hydrochloride prior
to procedures. Plasma concentrations of dox were moni-
tored ex vivo using a previously described assay [43].
Stocks of SIVmac239Δnef (SIVΔnef ) and SIV-rtTAΔnef
were grown on CEMX174 cells and stored at -70°C as
cell-free supernatants. The construction and optimization
of SIV-rtTAΔnef containing the rtTA-V16 variant with in-
creased dox-sensitivity and activity was described previ-
ously [24,25,44]. Viral titres were determined using C8166
cells. Twelve macaques receiving 100 mg dox daily per
oral were inoculated intravenously with 104 TCID50 SIV-
rtTAΔnef. After175 days dox was withdrawn from six of
the animals (Group A). Animals maintained on dox for
the duration of the experiment were designated Group B.
A further 6 animals were inoculated intravenously with
104 TCID50 SIVΔnef (Group C). All animals were sampled
regularly for peripheral blood.
Quantification of SIV RNA and proviral DNA
Quantitative real-time RT-PCR targeted to SIV gag was
used to determine plasma viral load as described previously
with a limit of detection of 50 SIV RNA/genome equiva-
lents copies per ml [45]. Tissue samples were digested with
proteinase K and phenol/chloroform following standard
protocols according to [46]. After DNA extraction, qPCR
was performed using Taqman Universal PCR Master mix
(Applied Biosystems) and primers and complementary
probes with sequences located in conserved gag regions as
reported for the qRT-PCR assay. SIV proviral DNA con-
centrations were calculated using the Mx3005P software,
expressed as copies of SIV DNA per 105 PBMC/mono-
nuclear cells (MNC). A single SIV DNA copy determined
the limit of assay detection, as determined by Poisson sta-
tistics and as previously reported [46].
Mononuclear cell isolation from peripheral blood and
small intestinal tissue
Peripheral blood mononuclear cells (PBMC) were sepa-
rated from 10 to 20 ml heparinised whole blood byPercoll gradient centrifugation. Small intestinal tissue
(approximately 30 g) was cut into small pieces (1-
2 cm) and digested with collagenase IV (Sigma). Tissue
mononuclear cells (MNC) were isolated using Percoll
density gradient. Briefly, pieces of tissues were washed
in calcium and magnesium-free HBSS (Gibco) for
20 min at 37°C. Cells released in suspension were con-
sidered intra-epithelial lymphocytes (IEL). For lamina
propria lymphocytes (LPL), pieces of tissue were
further digested with 50 μg/ml collagenase IV and
100 μg/ml DNAase (Sigma) and passed through a
mesh (70 mm pore size). The resulting material was
treated with 2 mg/ml DNAase at 37°C for 30 min and
MNCs were isolated using Percoll. Cells were re-
suspended in FCS/RPMI for analysis. Due to low cell
yields, IELs and LPLs from small intestinal tissue were
pooled for analysis.Immunohistochemical and In situ Hybridisation Analyses
Representative sections of lymphoid tissues and small
intestine were collected post mortem, fixed in 10% for-
mal saline and embedded in paraffin wax using stand-
ard histological procedures. Four micron sections were
cut and mounted on poly-L lysine coated slides. Prior
to any treatment sections were de-waxed in xylene and
re-hydrated via graded ethanol:water solutions. Sections
were then stained with haematoxylin and eosin using
standard histochemical procedures. In situ hybridisa-
tion for the detection of SIV RNA transcripts was
performed with digoxigenin (dig; Roche, Lewes, UK)
labelled single stranded DNA probes [47] in a cocktail
containing either three probes normal to or three
probes complementary with SIV transcripts using a
BondMax automated staining machine, utilising the Re-
search Mode option for protocol design and execution
(Leica Microsystems USA) [48]. Quantification of ISH
positive cells was performed by manually counting all
positive cells within up to 10 random fields of view
(×10 lens and ×10 eyepiece magnification; equivalent to
2.2 mm2) and data calculated as the mean number of
positive cells per mm2.
Immunohistochemical analyses were performed on a
BondMax automated staining machine. Sections were
treated using a 30 min HIER1 unmasking protocol and
stained using a Bond Polymer Refine staining system
and protocol (Leica Microsystems, USA) incorporating
an addition blocking treatment step (20 minutes at room
temperature using 20% normal horse serum, 1× casein
(Vector Laboratories) in 10 mM Tris/1 mM EDTA
pH 7.6) prior to the addition of KK13 monoclonal anti-
body specific for SIVgp120 [49]. Degrees of tissue stain-
ing were graded and used to generate mean scores
within each group of two animals.
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Peripheral and gut mononuclear cells were simultaneously
surface stained with anti-CD3-V500 (clone SP32, BD
Horizon), anti-CD4-V450 (clone L200, BD Horizon),
anti-CD8-APCCy7 (clone SK1, BD Biosciences), anti-
CD95-PECy7 (DX2, BioLegend), anti-CD28-PerCP-Cy5.5
(eBiosciences), anti-CCR7-FITC (R&D systems), anti-
β7-APC (BD Biosciences) and anti-CD49d-PE (α4, BD
Biosciences).
SIV-specific cellular immune responses were assessed
using multiparametric intracellular cytokine staining
(ICS) as described [50]. Briefly, thawed PBMCs were
washed and re-suspended at 2 × 106 cells/ml in RPMI
1640/10% FCS medium. Cells were then plated with
1 mg/ml CD49d, 1 mg/ml anti-CD28, Golgi Stop (10 ng/
ml, BD), and either 5 μg/ml of 15mer SIV Gag or Tat or
Rev pooled peptides (CFAR/NIBSC, Potters Bar, UK) and
incubated at 37°C in a 5% CO2 environment with RPMI
1640/10% FCS for 14 h. PBMC were incubated with
10 ng/ml of PMA (Sigma) and 1 μg/ml ionomycin (Sigma)
as positive controls. A negative control containing MNC
and co-stimulatory antibodies without the peptide mix,
was also included in each assay. After 2 hours, 10 ng/ml
monensin (BD Biosciences) was added to all cultures.
After incubation, cells were surface-stained with anti-
CD4-PECy7, anti-CD8-Alexa 488 and anti-CD3 V500 (BD
Biosciences), washed with PBS/2% FCS and fixed and
permeabilised with Fix and Perm kit (Caltag). Intracellular
cytokines were detected using anti-IFN-γ-PErCPCy5.5
(clone B27, BioLegend), anti-IL-2-PE (MQ1-17H21, ebio-
sciences), anti-TNF-α APC (MAB11, eBiosciences) and
anti-IL-17A-Pacific Blue (BioLegend). Finally, cells were
washed, fixed in PBS containing 1.5% paraformaldehyde
(Sigma) and stored at 4°C prior analysis. All samples were
analysed by flow cytometry (BD Canto II) within 24 h. In-
strument set up and data acquisition procedures were
performed according to BD Immunocytometry Systems
protocols. More than 200,000 and 50,000 events respect-
ively were acquired per sample, within the lymphocyte
population of PBMC and gut-derived MNC samples. Elec-
tronic compensation was applied using antibody-capture
beads (BD Biosciences) stained separately with individual
monoclonal antibodies. Data were analysed using BD
FACS Diva software. Lymphocyte subpopulations were
identified by gating on CD3+ cells and subsequently delin-
eating CD4, CD8, CD95, CCR7, CD28 and α4β7 expres-
sion. CD4 gating delineated a CD4high population, by
excluding weakly positive events (events located in regions
of low contour density, e.g. reference [51]). In this way,
non-conventional T cells such as NKT cells are excluded
from the analysis. For the identification of T cell memory
subsets, CD4+ and CD8+ cells were represented on con-
tour plots depicting staining intensity for the CD95 and
CD28 parameters. A quadrant was set according tofluorochrome/contour intensity [26] and used to discrim-
inate between the 4 phenotypic combinations. Differential
expression of CCR7 and CD28 was similarly determined
using a gating protocol based on that of Picker et al., [27].
To determine T cell polyfunctional cytokine responses
to SIV Gag, Rev and Tat peptide pools, a combination of
sequential plots were used delineating frequencies of
TNF-α, IL-2, IFN-γ and IL-17 expressing cells. Back-
ground responses detected in negative control samples
were subtracted for every specific functional combin-
ation. A threshold of >0.01% total CD4+ or CD8+ T cells
responding after subtraction of background was used as
a cut-off [52,53].
Statistical analysis
Statistical analyses, as specified, were performed using
Sigma Plot 11 (Systat Software, Inc.) and principal com-
ponent analysis was used to determine any signature
patterns of responsiveness (SSPS).
Additional files
Additional file 1: Figure S1. Plasma concentrations of soluble CD14 in
naïve and SIV-infected macaques after chronic infection. sCD14
concentrations were determined using a sCD14 ELISA (R&D Systems). Box
plots show 95th percentiles and median values. Dotted line shows limit of
detection.
Additional file 2: Figure S2. Analysis of multiparametric flow
cytometry data for signature patterns of cytokine expression. Principal
component analysis was used to determine any clustering of profiles of
intracellular cytokine expression in SIV peptide-stimulated PBMC taken
from macaques infected with SIV-rtTAΔnef and following withdrawal of
dox (replication non-permissive, Group A) or following maintenance of
dox (replication permissive, Group B) or infected with non-dox
dependent SIVΔnef (replication permissive, Group C). PCI shows principal
component scores accounting for as much variation in the original data
as possible i.e. the transformed data from the 18 animals analysed. PCII
accounts for much of the remaining variation as possible. Individual
animal numbers are shown on the plot and their group designated by
coloured symbols.
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